China's Crackdown on GlaxoSmithKline Bribery Scandal is A Warning to Foreign Firms, says Xinhua
Briton Mark Reilly and China's Zhang Guowei and Zhao Hongyan were charged with corruption in May
E.on Pays Record £12m Compensation Package for Mass Mis-selling
Ofgem slapped the energy giant with a record redress package for customer
Pfizer and AstraZeneca Deal 'Poses Threat to UK Science Industry'
Meanwhile, AstraZeneca is launching a research fund with the Medical Research Council's Laboratory of Molecular Biology
Libor Fixing: Martin Brokers Fined £630,000 as It Can't Afford £3.6m Charge
It is the second inter-dealer broker firm to be fined for Libor misconduct
Osborne 'Leaks' Dr Kristin Forbes BoE's Monetary Policy Committee Appointment on Twitter
Forbes was the youngest person to ever to serve as a Member of the White House's Council of Economic Advisers
Scottish Independence: Lloyds 'Not Moving' Ahead of Referendum Despite Potential Financial Exodus
Elsewhere, a raft of financials are preparing for Scotland possible breaking away from the UK
Lloyds Defends Banker Bonuses Worth 200% of Salaries for 'Retaining Talent'
Lloyds says 'executive pay is strongly linked to shareholders objectives'
Euromoney Shares Slump as Financial Institutions Curb Costs
Euromoney Institutional Investor is owned by the Daily Mail & General Trust
Criminals Launder $140bn Annually Through Sports Betting
Football and cricket are the sports most threatened by criminal gangs, says the ICSS
WPP's Grey Acquires South Africa's Volcano Group Amid M&A Frenzy
This is WPP's second South African acquisition in two weeks after it snapped up Quirk
Pfizer Has Not Discussed AstraZeneca Takeover Bid with Regulators, Warns EU Chief
Competition Commissioner Joaquin Almunia said there has been 'no contact, no conversation'
Barclays Top Asia Investment Banker Matthew Ginsburg Stepping Down
Co-CEO for Asia Pacific Andrew Jones will become interim head of investment banking in the region
UK Tax Avoidance Crackdown Inflated by Osborne's Use of 'Dodgy Statistics'
HMRC and Whitehall are using new measures to calculate tax recovery from five years ago.
Lloyds Faces Shareholder Grilling Over Banker Bonuses
Lloyds gained government support to pay bonuses worth 200% of salaries.
Mis-selling Derivatives Victims Eye Mass Bank Lawsuits Post-FCA Review
Exclusive: Bully-Banks Chairman reveals plans after businesses feel 'let down' by the FCA review
Mis-selling Derivatives Victims Eye Mass Bank Lawsuits Post FCA Review
SMEs that believe they have been mis-sold complex interest rate swap agreements are looking to band together to take Britain's biggest banks to court.
UK Jobs Market Slack Masked by 'Rise in Selfies', says Schroders
Rise in self-employment could mean there is an overstatement in the labour market recovery
GlaxoSmithKline Seeks China Bribery Scandal Resolution as Mark Reilly and Execs Charged With Corruption
China charged former boss of GSK's China unit, Mark Reilly, and two other executives with corruption
ITV Shares Tumble Amid Revenue Drop and Cost Savings
On track to deliver £10m cost savings over the full year
Barclays Vice Chairman of Asia Pacific M&A Jason Rynbeck Leaves
Barclays Asia-Pacific chairman and chief executive Robert Morrice left earlier this month.
Scottish Independence: Standard Life Unveils Blueprint for Financial Services Exodus
Standard Life Chairman Gerry Grimstone said the Yes campaign has not given the 'fine print' over possible independence
Co-op Board Member and Labour Councillor Munir Malik Leaves Amid Qualification Probe
Malik was under internal investigation for qualification claims when seeking board re-election
GlaxoSmithKline's Former China Boss Mark Reilly and Two Others Charged With Corruption
Two Chinese executives, Zhang Guowei and Zhao Hongyan, are also suspected of bribing officials.
AstraZeneca and Pfizer Deal: Cable Calms Fears Over Government's Intervention Powers
Vince Cable adds Pfizer's open letter was the starting point for negotiations, not a binding proposal
AstraZeneca Fears Pfizer Bid Would Disrupt Jobs, Medicine and Reputation
Drugmaker's CEO Pascal Soriot said long-term commitments wouldn't make a difference to substantial short term disruption
Pfizer Eyes 'Lower R&D Spend and Tax Rates' If AstraZeneca Deal Completes
Pfizer's Ian Read still insists that it cannot figure the number of UK jobs possibly affected by the takeover.
Pfizer's AstraZeneca Takeover Slammed By Unite and GMB for 'Flimsy Commitments' to UK Workforce
Unions say Pfizer should sign up to a legally binding agreement, saving UK jobs following a takeover.
China Unveiling GlaxoSmithKline Bribery Investigation Details
China accuses GSK executives of routing 3bn yuan in bribes to doctors through travel agencies and consultancies
Disney's Frozen Reels in $1.19bn in Global Ticket Sales
The children's film about two royal sisters in a frosty kingdom has also boosted Disney's balance sheet
Pfizer Pressures AstraZeneca's Board Ahead of Westminster Grilling
US drug maker and Britain's second largest pharmaceutical are giving evidence at the Business Select Committee
